Citigroup’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59K | Sell |
2,075
-11,810
| -85% | -$14.8K | ﹤0.01% | 4596 |
|
|
2025
Q1 | $44.8K | Sell |
13,885
-1,351
| -9% | -$4.36K | ﹤0.01% | 4133 |
|
|
2024
Q4 | $62.8K | Buy |
15,236
+11,750
| +337% | +$48.4K | ﹤0.01% | 4175 |
|
|
2024
Q3 | $22.4K | Sell |
3,486
-3,068
| -47% | -$19.7K | ﹤0.01% | 4382 |
|
|
2024
Q2 | $31.5K | Sell |
6,554
-11,194
| -63% | -$53.8K | ﹤0.01% | 4097 |
|
|
2024
Q1 | $92.8K | Buy |
+17,748
| New | +$92.8K | ﹤0.01% | 3590 |
|